Orthopedic Oncology Treatment Market Insights, Global Outlook and Forecast 2022-2028
Orthopedic Oncology Treatment Market Insights, Global Outlook and Forecast 2022-2028
The Orthopedic Oncology Treatment study provides a comprehensive overview of safety standards, market penetration, and innovation pipelines across major economies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Orthopedic oncology accounts for a very small percentage in the field of orthopedics due to fact that the incidences of bone and soft tissue tumors are rare as compared to the benign tumors of musculoskeletal system which includes trauma, spine, hand and upper extremity, total joints and even pediatric orthopedics.
The latest research study released by Market IntelliX evaluates market size and forecasts of Orthopedic Oncology Treatment in Global, including the following market information:
Global Orthopedic Oncology Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Orthopedic Oncology Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Soft Tissue Excisions/Resections Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Orthopedic Oncology Treatment include Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, DePuy Synthes (Johnson & Johnson), Medtronic, Accentus Medical, Roche Holding AG, Amgen, Inc. and Novartis AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Orthopedic Oncology Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Orthopedic Oncology Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Orthopedic Oncology Treatment Market Segment Percentages, by Type, 2021 (%)
Soft Tissue Excisions/Resections
Limb Salvage Surgery
Amputation
Adjuvant Chemotherapy
Reconstructive Surgery
Global Orthopedic Oncology Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Orthopedic Oncology Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinic
Others
Global Orthopedic Oncology Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Orthopedic Oncology Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Orthopedic Oncology Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Orthopedic Oncology Treatment revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Stryker Corporation
Zimmer Biomet Holdings, Inc.
Smith & Nephew plc
DePuy Synthes (Johnson & Johnson)
Medtronic
Accentus Medical
Roche Holding AG
Amgen, Inc.
Novartis AG
GlaxoSmithKline
Sanofi
Pfizer Inc.
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Orthopedic Oncology Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Orthopedic Oncology Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Orthopedic Oncology Treatment Overall Market Size
2.1 Global Orthopedic Oncology Treatment Market Size: 2021 VS 2028
2.2 Global Orthopedic Oncology Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Orthopedic Oncology Treatment Players in Global Market
3.2 Top Global Orthopedic Oncology Treatment Companies Ranked by Revenue
3.3 Global Orthopedic Oncology Treatment Revenue by Companies
3.4 Top 3 and Top 5 Orthopedic Oncology Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Orthopedic Oncology Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Orthopedic Oncology Treatment Players in Global Market
3.6.1 List of Global Tier 1 Orthopedic Oncology Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Orthopedic Oncology Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Orthopedic Oncology Treatment Market Size Markets, 2021 & 2028
4.1.2 Soft Tissue Excisions/Resections
4.1.3 Limb Salvage Surgery
4.1.4 Amputation
4.1.5 Adjuvant Chemotherapy
4.1.6 Reconstructive Surgery
4.2 By Type - Global Orthopedic Oncology Treatment Revenue & Forecasts
4.2.1 By Type - Global Orthopedic Oncology Treatment Revenue, 2017-2022
4.2.2 By Type - Global Orthopedic Oncology Treatment Revenue, 2023-2028
4.2.3 By Type - Global Orthopedic Oncology Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Orthopedic Oncology Treatment Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Orthopedic Oncology Treatment Revenue & Forecasts
5.2.1 By Application - Global Orthopedic Oncology Treatment Revenue, 2017-2022
5.2.2 By Application - Global Orthopedic Oncology Treatment Revenue, 2023-2028
5.2.3 By Application - Global Orthopedic Oncology Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Orthopedic Oncology Treatment Market Size, 2021 & 2028
6.2 By Region - Global Orthopedic Oncology Treatment Revenue & Forecasts
6.2.1 By Region - Global Orthopedic Oncology Treatment Revenue, 2017-2022
6.2.2 By Region - Global Orthopedic Oncology Treatment Revenue, 2023-2028
6.2.3 By Region - Global Orthopedic Oncology Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Orthopedic Oncology Treatment Revenue, 2017-2028
6.3.2 US Orthopedic Oncology Treatment Market Size, 2017-2028
6.3.3 Canada Orthopedic Oncology Treatment Market Size, 2017-2028
6.3.4 Mexico Orthopedic Oncology Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Orthopedic Oncology Treatment Revenue, 2017-2028
6.4.2 Germany Orthopedic Oncology Treatment Market Size, 2017-2028
6.4.3 France Orthopedic Oncology Treatment Market Size, 2017-2028
6.4.4 U.K. Orthopedic Oncology Treatment Market Size, 2017-2028
6.4.5 Italy Orthopedic Oncology Treatment Market Size, 2017-2028
6.4.6 Russia Orthopedic Oncology Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Orthopedic Oncology Treatment Market Size, 2017-2028
6.4.8 Benelux Orthopedic Oncology Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Orthopedic Oncology Treatment Revenue, 2017-2028
6.5.2 China Orthopedic Oncology Treatment Market Size, 2017-2028
6.5.3 Japan Orthopedic Oncology Treatment Market Size, 2017-2028
6.5.4 South Korea Orthopedic Oncology Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Orthopedic Oncology Treatment Market Size, 2017-2028
6.5.6 India Orthopedic Oncology Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Orthopedic Oncology Treatment Revenue, 2017-2028
6.6.2 Brazil Orthopedic Oncology Treatment Market Size, 2017-2028
6.6.3 Argentina Orthopedic Oncology Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Orthopedic Oncology Treatment Revenue, 2017-2028
6.7.2 Turkey Orthopedic Oncology Treatment Market Size, 2017-2028
6.7.3 Israel Orthopedic Oncology Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Orthopedic Oncology Treatment Market Size, 2017-2028
6.7.5 UAE Orthopedic Oncology Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Stryker Corporation
7.1.1 Stryker Corporation Corporate Summary
7.1.2 Stryker Corporation Business Overview
7.1.3 Stryker Corporation Orthopedic Oncology Treatment Major Product Offerings
7.1.4 Stryker Corporation Orthopedic Oncology Treatment Revenue in Global Market (2017-2022)
7.1.5 Stryker Corporation Key News
7.2 Zimmer Biomet Holdings, Inc.
7.2.1 Zimmer Biomet Holdings, Inc. Corporate Summary
7.2.2 Zimmer Biomet Holdings, Inc. Business Overview
7.2.3 Zimmer Biomet Holdings, Inc. Orthopedic Oncology Treatment Major Product Offerings
7.2.4 Zimmer Biomet Holdings, Inc. Orthopedic Oncology Treatment Revenue in Global Market (2017-2022)
7.2.5 Zimmer Biomet Holdings, Inc. Key News
7.3 Smith & Nephew plc
7.3.1 Smith & Nephew plc Corporate Summary
7.3.2 Smith & Nephew plc Business Overview
7.3.3 Smith & Nephew plc Orthopedic Oncology Treatment Major Product Offerings
7.3.4 Smith & Nephew plc Orthopedic Oncology Treatment Revenue in Global Market (2017-2022)
7.3.5 Smith & Nephew plc Key News
7.4 DePuy Synthes (Johnson & Johnson)
7.4.1 DePuy Synthes (Johnson & Johnson) Corporate Summary
7.4.2 DePuy Synthes (Johnson & Johnson) Business Overview
7.4.3 DePuy Synthes (Johnson & Johnson) Orthopedic Oncology Treatment Major Product Offerings
7.4.4 DePuy Synthes (Johnson & Johnson) Orthopedic Oncology Treatment Revenue in Global Market (2017-2022)
7.4.5 DePuy Synthes (Johnson & Johnson) Key News
7.5 Medtronic
7.5.1 Medtronic Corporate Summary
7.5.2 Medtronic Business Overview
7.5.3 Medtronic Orthopedic Oncology Treatment Major Product Offerings
7.5.4 Medtronic Orthopedic Oncology Treatment Revenue in Global Market (2017-2022)
7.5.5 Medtronic Key News
7.6 Accentus Medical
7.6.1 Accentus Medical Corporate Summary
7.6.2 Accentus Medical Business Overview
7.6.3 Accentus Medical Orthopedic Oncology Treatment Major Product Offerings
7.6.4 Accentus Medical Orthopedic Oncology Treatment Revenue in Global Market (2017-2022)
7.6.5 Accentus Medical Key News
7.7 Roche Holding AG
7.7.1 Roche Holding AG Corporate Summary
7.7.2 Roche Holding AG Business Overview
7.7.3 Roche Holding AG Orthopedic Oncology Treatment Major Product Offerings
7.7.4 Roche Holding AG Orthopedic Oncology Treatment Revenue in Global Market (2017-2022)
7.7.5 Roche Holding AG Key News
7.8 Amgen, Inc.
7.8.1 Amgen, Inc. Corporate Summary
7.8.2 Amgen, Inc. Business Overview
7.8.3 Amgen, Inc. Orthopedic Oncology Treatment Major Product Offerings
7.8.4 Amgen, Inc. Orthopedic Oncology Treatment Revenue in Global Market (2017-2022)
7.8.5 Amgen, Inc. Key News
7.9 Novartis AG
7.9.1 Novartis AG Corporate Summary
7.9.2 Novartis AG Business Overview
7.9.3 Novartis AG Orthopedic Oncology Treatment Major Product Offerings
7.9.4 Novartis AG Orthopedic Oncology Treatment Revenue in Global Market (2017-2022)
7.9.5 Novartis AG Key News
7.10 GlaxoSmithKline
7.10.1 GlaxoSmithKline Corporate Summary
7.10.2 GlaxoSmithKline Business Overview
7.10.3 GlaxoSmithKline Orthopedic Oncology Treatment Major Product Offerings
7.10.4 GlaxoSmithKline Orthopedic Oncology Treatment Revenue in Global Market (2017-2022)
7.10.5 GlaxoSmithKline Key News
7.11 Sanofi
7.11.1 Sanofi Corporate Summary
7.11.2 Sanofi Business Overview
7.11.3 Sanofi Orthopedic Oncology Treatment Major Product Offerings
7.11.4 Sanofi Orthopedic Oncology Treatment Revenue in Global Market (2017-2022)
7.11.5 Sanofi Key News
7.12 Pfizer Inc.
7.12.1 Pfizer Inc. Corporate Summary
7.12.2 Pfizer Inc. Business Overview
7.12.3 Pfizer Inc. Orthopedic Oncology Treatment Major Product Offerings
7.12.4 Pfizer Inc. Orthopedic Oncology Treatment Revenue in Global Market (2017-2022)
7.12.5 Pfizer Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Orthopedic Oncology Treatment Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|